Status:
ACTIVE_NOT_RECRUITING
The LvL UP Trial: Assessing the Effectiveness of a MHealth Intervention
Lead Sponsor:
Singapore ETH Centre
Collaborating Sponsors:
ETH Zurich
National University of Singapore
Conditions:
Health Behavior
Noncommunicable Diseases
Eligibility:
All Genders
21-59 years
Phase:
NA
Brief Summary
Non-communicable diseases (NCDs), such as cardiovascular disease, diabetes, or cancer, and common mental disorders (CMDs), such as depression or anxiety, represent the primary causes of death and disa...
Detailed Description
Participants will: * Visit the study site at baseline and month 6 to complete assessments. * Complete online assessments at months 1, 3, 9 and 12. * Be assigned to group 1 (intervention) or group 2 (...
Eligibility Criteria
Inclusion
- (i) aged 21 to 59 years,
- (ii) Singapore citizens, permanent residents, or foreigners residing in Singapore on long-term passes with at least 1 year of validity remaining,
- (iii) planning to reside in Singapore for the duration of the study (eligible participants can undertake sporadic trips overseas, as long as these do not conflict with in-person study visits),
- (iv) proficient in English (the LvL UP app is currently only available in English),
- (v) owners of a smartphone (minimum requirements: iOS version 12.4 and Android version 8) with internet access,
- (vi) able to provide informed consent, and
- (vii) identified as 'at risk' of developing non-communicable diseases and/or common mental disorders.
Exclusion
- (i) diagnosed with one of the following chronic diseases: heart disease (e.g., heart attack and stroke), cancer, chronic respiratory diseases (e.g., chronic obstructed pulmonary disease and asthma), diabetes (type 1 or type 2), or chronic kidney disease.
- (ii) diagnosed with one of the following mental disorders: major depressive disorders (depression), bipolar, eating disorders, post-traumatic stress disorder (PTSD), anxiety disorders, severe personality disorder, substance use disorders, or other mental health conditions diagnosed by a mental health professional.
- (iii) pregnant, (iv) currently taking medications prescribed for high blood pressure or high blood glucose.
- (v) past or current LvL UP users, including participants from the LvL UP pilot trial (NCT06360029) or HAPPY trial (Harnessing Human Potential and Improving Health Span in Women and their Children Trial).
- (vi) already participating or planning to participate in the LvL UP trial as a 'LvL UP Buddy\'.
- (vii) enrolled or planning to enroll in another lifestyle intervention research study before or during the study period.
Key Trial Info
Start Date :
October 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
1073 Patients enrolled
Trial Details
Trial ID
NCT06592443
Start Date
October 21 2024
End Date
February 1 2026
Last Update
February 19 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Saw Swee Hock School of Public Health
Singapore, Singapore, 117549
2
Singapore ETH Center
Singapore, Singapore, 138602